Aurinia Pharmaceuticals stock surges 4% on plans to pursue a possible sale

This post was originally published on this site

https://i-invdn-com.investing.com/news/LYNXNPEE7M0VV_M.jpg

There is no guarantee that this exploration will lead to any specific transaction or strategic outcome. The company has not established a timeline for concluding this process, and it does not plan to disclose additional updates unless it deems it necessary or appropriate to do so.